LALWANI NIKHIL (PRESIDENT & CEO) received a stock award from ANI PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 3/2/2026ACC: 0001822629-26-000006
DirectorOfficer· PRESIDENT & CEO
Since Sep 2020
+63.38K
Net shares
Net buyer
$902.8K
Total sold
0
Open market trades
0B · 0S
2
Total transactions
75.59K acquired · 12.22K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+75.59K
Price / share
$77.15
Trade value
$5.83M
% of position
21.1%
2/26/2026
358.57K→434.17K
Common Stock
Direct
Shares
−12.22K
Price / share
$73.90
Trade value
$902.84K
% of position
2.8%
2/28/2026
434.17K→421.95K
Total
Net shares
+63.38K
Net value
$4.93M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/26/2026 | A · Award | +75.59K | $77.15 | $5.83M | 21.1% | 358.57K | 434.17K |
| Common Stock Direct | 2/28/2026 | F · Tax Withholding | −12.22K | $73.90 | $902.84K | 2.8% | 434.17K | 421.95K |
| Total | +63.38K | $4.93M | ||||||
Derivative Transactions0
No derivative transactions reported